Features

Top 25 Pharma and Biopharma Companies

(Based on 2018 Pharma/Biopharma Sales, in $U.S. Millions)

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

By: Kristin Brooks

Managing Editor, Contract Pharma

The 2020 version is ready and live online. Click here to review the latest Top Companies list!

Top 25 Pharma and Biopharma Companies (Based on 2018 Pharma/Biopharma Sales, in $U.S. Millions)


01. Pfizer $53,647
02. Novartis $44,751
03. Roche $44,654
04. Johnson & Johnson $40,734
05. Sanofi $39,419
06. Merck & Co. $37,689
07. AbbVie $32,753
08. GlaxoSmithKline $30,807
09. Eli Lilly & Co. $24,556
10. Amgen $23,747
11. Bristol-Myers Squibb $22,561
12. Gilead $22,127
13. AstraZeneca $22,090
14. Bayer $19,154
15. Teva $18,854
16. Novo Nordisk $17,127
17. Takeda $15,967
18. Allergan $15,787
19. Celgene $15,281
20. Boehringer-Ingelheim $15,204
21. Biogen $13,543
22. Astellas $11,781
23. Otsuka $11,710
24. Mylan $11,434
25. Daiichi Sankyo $8,659


Contributors

Editor: Tim Wright
Managing Editor: Kristin Brooks

*Pipeline information has been provided by and in partnership with Evaluate (www.evaluate.com)

*Profile information is sourced from each company’s annual report along with press releases distributed throughout the year. Pharma/biopharmaceutical sales are the primary factor in the rankings, however results may include animal heath sales where applicable and other smaller division sales. Large medical device, diagnostics, and consumer care division revenues have been excluded from the rankings.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters